Donor complications among 500 living donor liver transplantations at a single center

D Ozgor1, A Dirican, M Ates

  • 1Department of Surgery and Liver Transplantation Unit, Inonu University, Malatya, Turkey.

Insights

Living donor liver transplantation (LDLT) involves donor hepatectomy with an 18.6% complication rate, but no donor mortality was observed. Biliary issues were most common, with most complications being minor.

Area of Science:

  • Hepatobiliary Surgery
  • Transplant Surgery
  • Surgical Outcomes Research

Background:

  • Increasing demand for liver transplantation necessitates living donor liver transplantation (LDLT).
  • Donor safety is paramount in LDLT procedures.
  • The Clavien classification system is utilized to standardize complication grading.

Purpose of the Study:

  • To retrospectively analyze the incidence and severity of complications in living liver donors.
  • To evaluate donor safety outcomes following hepatectomy for LDLT.

Main Methods:

  • Retrospective analysis of 500 consecutive living donors undergoing hepatectomy for LDLT.
  • Application of the Clavien classification system to grade all reported complications.
  • Follow-up of donors for a mean of 30 months post-surgery.

Main Results:

  • 18.6% of donors (93/500) experienced 149 complications; no donor mortality occurred.
  • The majority of complications were minor (Grade I/II), while major complications (Grade III/IV) occurred in 42.1% of complicated cases.
  • Biliary complications were the most frequent, occurring in 7.7% of donors.

Conclusions:

  • Living liver donation is associated with a manageable range of complications.
  • The Clavien classification effectively grades the severity of donor complications in LDLT.
  • LDLT donor hepatectomy demonstrates a favorable safety profile with no reported mortality.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...